Research progress on radical concurrent chemoradiotherapy for locally advanced esophageal cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6): 1065-1069, 2022.
Artigo
em Chinês
| WPRIM
| ID: wpr-956955
ABSTRACT
The current standard treatment modality for unresectable locally advanced esophageal cancer is radical concurrent chemoradiotherapy. In this article, research progress on radiotherapy techniques, differences in radiotherapy dose and target volume, exploration in concurrent chemotherapy and immunotherapy was reviewed, aiming to provide reference and evidence for clinical treatment.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Radiation Oncology
Ano de publicação:
2022
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS